✦ LIBER ✦

Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan

✍ Scribed by Kunihiro Yamagata; Hirofumi Makino; Tadao Akizawa; Kunitoshi Iseki; Sadayoshi Itoh; Kenjiro Kimura; Daisuke Koya; Ichiei Narita; Tetsuya Mitarai; Masanobu Miyazaki; Yoshiharu Tsubakihara; Tsuyoshi Watanabe; Takashi Wada; Osamu Sakai; Advisory Committee for FROM-J

Publisher: Springer
Year: 2009
Tongue: English
Weight: 235 KB
Volume: 14
Category: Article
ISSN: 1342-1751
DOI: 10.1007/s10157-009-0249-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperparathyroidism in chronic kidney di

Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes

✍ David H. Smith; Eric S. Johnson; Micah L. Thorp; Xiuhai Yang; Nancy Neil 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 182 KB

Study design and methods for a clinical

Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD)

✍ Satoshi Morita; Shunichi Fukuhara; Tadao Akizawa; Yasushi Asano; Kiyoshi Kurokaw 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 776 KB

Interim evidence of the renoprotective e

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

✍ Yasuhiko Iino; Matsuhiko Hayashi; Tetsuya Kawamura; Tatsuo Shiigai; Yasuhiko Tom 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 613 KB